ProtiFi has remained fully operational during these difficult times and stands ready to assist your research. To support researchers in government, military and health agencies, as well as biotech and scientific institutions, we expanded operations during the SARS-CoV-2/COVID-19 pandemic. We added additional manufacturing capacity and strengthened our manufacturing and supply chains. To accelerate innovation in and research and development of clinical treatments, vaccines and diagnostics, we also extended our partnerships and collaborations. For example, using the Tecan Resolvex® A200 automated positive pressure workstation, labs are now processing >10,000 samples per day with a single operator. ProtiFi technologies are ideally suited to assist in SARS-CoV-2/COVID-19 research and have been used in the studies listed below. Speed and agility are essential to address this fast-moving pandemic; please reach out if you have unmet research needs.